Long-Term Effects of Sublingual Grass Therapy
NCT01335139 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 106
Last updated 2017-06-02
Summary
The purpose of this research study is to investigate whether sublingual immunotherapy (SLIT, grass pollen tablets under the tongue) has long term effects in severe hay fever.
Conditions
- Rhinitis, Allergic, Seasonal
Interventions
- BIOLOGICAL
-
Sublingual immunotherapy (SLIT)
Participants randomized to receive sublingual allergen tablet immunotherapy with placebo injections.
- BIOLOGICAL
-
Subcutaneous immunotherapy (SCIT)
Participants randomized to receive subcutaneous injection immunotherapy with placebo tablets. Subcutaneous immunotherapy was included as a positive control.
- OTHER
-
Placebo
Participants randomized to double-placebo tablets and injections. This group was included as a negative control.
Sponsors & Collaborators
-
Immune Tolerance Network (ITN)
collaborator NETWORK -
Imperial College London
collaborator OTHER -
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Stephen Durham, MD · Imperial College London
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2015-02-28
- Completion
- 2015-02-28
Countries
- United Kingdom
Study Locations
More Related Trials
-
Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis
NCT00367640 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
NCT00409409 ·Status: COMPLETED ·Phase: PHASE3
-
Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis
NCT02245360 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies
NCT00599872 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy
NCT01500642 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Sublingual Immunotherapy (SLIT)
NCT01012882 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis
NCT00803244 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)
NCT00978029 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability Study of Ragweed SLIT Tablets
NCT01224834 ·Status: COMPLETED ·Phase: PHASE1
-
Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction
NCT04502966 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua
NCT03990272 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Benefits of Sublingual AIT (PRACTIS)
NCT06574061 ·Status: COMPLETED
-
Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma
NCT00135642 ·Status: COMPLETED ·Phase: PHASE3
-
Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen
NCT00916422 ·Status: COMPLETED ·Phase: PHASE3
-
Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis
NCT03649139 ·Status: COMPLETED ·Phase: PHASE3
-
Sublingual Immunotherapy in Children With Allergic Rhinitis
NCT01506843 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
NCT04891237 ·Status: RECRUITING ·Phase: PHASE3
-
ILIT: Follow-up of Rhinitis Quality of Life
NCT05037955 ·Status: COMPLETED
-
Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1
NCT00396149 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions
NCT01878929 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis
NCT04878354 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children
NCT01199133 ·Status: TERMINATED ·Phase: PHASE3
-
Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract
NCT05297760 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis
NCT00550875 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children
NCT00841256 ·Status: COMPLETED ·Phase: PHASE3